Simplex Trading, LLC Adaptimmune Therapeutics PLC Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Simplex Trading, LLC holds 1,052 shares of ADAP stock, worth $620. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,052

Holding current value

$620

% of portfolio

0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$0.92 - $1.39 $967 - $1,462	1,052 New	1,052 $0
Q4 2023 Feb 02, 2024	BUY	$0.43 - $0.79 $129 - $237	300 New	300 $0
Q2 2023 Aug 04, 2023	SELL	$0.9 - $1.51 $3,312 - $5,558	-3,681 Reduced 28.12%	9,408 $8,000
Q1 2023 Apr 27, 2023	BUY	$1.06 - $2.16 $8,464 - $17,247	7,985 Added 156.45%	13,089 $14,000
Q4 2022 Feb 02, 2023	BUY	$1.05 - $2.53 $3,965 - $9,555	3,777 Added 284.63%	5,104 $7,000
Q3 2022 Nov 04, 2022	SELL	$1.06 - $2.41 $12,963 - $29,474	-12,230 Reduced 90.21%	1,327 $1,000
Q2 2022 Aug 03, 2022	BUY	$1.33 - $2.28 $12,162 - $20,850	9,145 Added 207.28%	13,557 $23,000
Q1 2022 May 02, 2022	SELL	$1.73 - $4.06 $8,772 - $20,588	-5,071 Reduced 53.47%	4,412 $9,000
Q4 2021 Feb 23, 2022	SELL	$3.5 - $5.68 $13,587 - $22,049	-3,882 Reduced 29.05%	9,483 $35,000
Q3 2021 Oct 28, 2021	SELL	$3.44 - $6.37 $32,043 - $59,336	-9,315 Reduced 41.07%	13,365 $58,000
Q2 2021 Aug 12, 2021	SELL	$3.86 - $5.78 $44,752 - $67,013	-11,594 Reduced 33.83%	22,680 $96,000
Q1 2021 Apr 26, 2021	BUY	$4.9 - $6.83 $38,553 - $53,738	7,868 Added 29.8%	34,274 $181,000
Q4 2020 Feb 02, 2021	BUY	$4.0 - $9.2 $105,624 - $242,935	26,406 New	26,406 $142,000
Q3 2020 Oct 14, 2020	SELL	$7.66 - $10.78 $13,129 - $18,476	-1,714 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$2.58 - $12.1 $3,704 - $17,375	-1,436 Reduced 45.59%	1,714 $17,000
Q1 2020 Apr 29, 2020	BUY	$1.2 - $4.52 $3,780 - $14,237	3,150 New	3,150 $8,000
Q4 2019 Feb 05, 2020	SELL	$0.72 - $1.43 $46 - $92	-65 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$1.43 - $3.81 $1,916 - $5,105	-1,340 Reduced 95.37%	65 $0
Q2 2019 Jul 26, 2019	SELL	$3.23 - $5.41 $2,283 - $3,824	-707 Reduced 33.48%	1,405 $5,000
Q1 2019 Apr 18, 2019	BUY	$3.63 - $6.06 $7,666 - $12,798	2,112 New	2,112 $0
Q4 2018 Jan 16, 2019	SELL	$3.76 - $14.16 $32,411 - $122,059	-8,620 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$8.27 - $13.56 $3,407 - $5,586	412 Added 5.02%	8,620 $116,000
Q2 2018 Jul 30, 2018	BUY	$10.42 - $13.74 $63,416 - $83,621	6,086 Added 286.8%	8,208 $97,000
Q1 2018 Apr 26, 2018	BUY	$7.1 - $11.56 $15,066 - $24,530	2,122 New	2,122 $23,000
Q4 2017 Jan 10, 2018	SELL	$6.68 - $8.74 $581 - $760	-87 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$4.93 - $8.93 $428 - $776	87	87 $0

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$22.2 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$16.2 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$10.1 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$9.9 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$7.85 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $96.4M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account